{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the titles and passages are a bit confusing. Let me check again.\n\nThe context has four entries. The first three are titled \"Estimating the number of infections and the impact of non-\" with the passage \"Lockdown\" each time. The fourth title is the same but the passage is \"banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe there's a formatting issue here. The user might be referring to a study or report where lockdowns are discussed in the context of controlling infections, possibly during a pandemic like COVID-19.\n\nThe question is straightforward: defining a lockdown. The answer should explain that a lockdown is a public health measure where people are required to stay at home, non-essential businesses are closed, and movement is restricted to prevent the spread of a disease. The context mentions the impact of non-lockdown measures, so maybe the study compared lockdowns to other interventions. But the user just wants a definition. I need to make sure the answer is clear and concise, using the context if possible. However, the provided context is a bit fragmented. Since the titles mention estimating infections and the impact of non-lockdown, perhaps the study found that lockdowns were implemented to reduce infections. But the answer should focus on defining a lockdown. Let me structure the answer accordingly, making sure it's accurate and based on general knowledge since the context isn't very informative.\n</think>\n\nA **lockdown** is a public health measure implemented to restrict movement and gatherings of people, typically during a pandemic or outbreak, to slow the spread of a contagious disease. It often involves closing non-essential businesses, schools, and public spaces, limiting travel, and requiring individuals to stay at home except for essential activities. The goal is to reduce person-to-person transmission and prevent healthcare systems from becoming overwhelmed. The context provided suggests that lockdowns were studied as a critical intervention to estimate their impact on reducing infections compared to non-lockdown measures.",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know stands for Chikungunya virus. Let me look back at the provided context to find the answer.\n\nFirst, the passage mentions several groups affected by severe CHIKF (Chikungunya Fever). It lists the complications from most common to least common. The main ones are respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure. \n\nThen there's a part about neonates. The mothers can transmit the virus during the perinatal period, leading to high morbidity. The neonates showed symptoms by day 4, and six had meningoencephalitis. So that's another complication related to transmission to newborns.\n\nI need to make sure I include all the complications listed. Let me check again. The passage says \"Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.\" \n\nAlso, the neonatal transmission leads to meningoencephalitis specifically. So maybe that's part of the central nervous system complications mentioned. But since it's highlighted in the neonate section, should I mention that separately? The question is about complications in general, so probably include all the listed ones. \n\nSo the answer should list all the complications in order, and maybe note the neonatal transmission part as an additional point. Let me structure that clearly.\n</think>\n\nThe complications associated with CHIKV (Chikungunya virus) include:  \n1. **Respiratory failure**  \n2. **Cardiovascular decompensation**  \n3. **Meningoencephalitis** (including in neonates transmitted perinatally)  \n4. **Severe acute hepatitis**  \n5. **Severe cutaneous effects**  \n6. **Other central nervous system problems**  \n7. **Kidney failure**  \n\nAdditionally, perinatal transmission of CHIKV to neonates is associated with high morbidity, with symptoms appearing by day 4 of life and complications such as **meningoencephalitis** in confirmed cases. Underlying medical conditions in adults also contribute to severe outcomes.",
      "retrieved_chunks": [
        "Passage: More than 50% of patients who suffer from severe CHIKF are over 65 y old, and more than 33% of them die. Most adults who suffer from severe CHIKF have underlying medical conditions . The other group that is disproportionately affected by severe CHIKV is children. Other complications associated with CHIKV, from most common to least common, include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure .",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?",
        "Title: Chikungunya: A Potentially Emerging Epidemic?"
      ],
      "computed_relevance": 0.2,
      "computed_utilization": 0.7,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about Clade A, but looking through the given passages, I don't see any mention of a clade labeled \"A\". The context talks about clades like 1B.1, 1B.2, 1B.1.1, and 1C.2, but there's no reference to Clade A. \n\nThe first passage mentions that each clade had an APD (Average Pairwise Distance) of more than 7% from other clades and less than 7% within the clade, except for some exceptions like 1B.1 and 1B.2. The second passage also discusses similar points and mentions the 1C.2 clade as an exception. The titles and other passages refer to a nomenclature system for H1 hemagglutinin genes in swine influenza, but again, no Clade A is mentioned.\n\nSince the question is about Clade A and the provided context doesn't mention Clade A at all, it's possible that there's a mistake in the question or that the information isn't present here. The answer should probably state that there's no information on Clade A in the given context.\n</think>\n\nThe provided context does not mention or describe \"Clade A.\" The text references clades such as 1B.1, 1B.2, 1B.1.1, and 1C.2, but there is no information about a clade labeled \"A.\" Therefore, based on the given context, **Clade A is not discussed or defined**.",
      "retrieved_chunks": [
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and almost all had an APD of \u03fd7% within the clade. The within-clade exceptions were the 1B.1 and 1B.2 clades . The 1B.1 second-order clade had too few representative sequences to calculate genetic distance, and 1B.2 represented multiple monophyletic clades that individually did not meet our criteria for further division. Similarly, the extensive 1B.1.1 clade did not meet criteria for further splitting.",
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 .",
        "The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations ."
      ],
      "computed_relevance": 0.6666666666666666,
      "computed_utilization": 0.6666666666666666,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The passage mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. However, it also states that the core domain of the RBD (receptor binding domain) is highly conserved. \n\nWait, the S1 subunit's overall identity is 70%, but the RBD core is more conserved. The S2 subunit is mentioned as being 99% identical, which is highly conserved. The question is specifically about S1. \n\nSo the answer should note the 70% identity for the S1 subunit compared to the others, but also mention that the RBD core is highly conserved. The user might be confused if they think the entire S1 is 70%, but part of it (RBD) is more conserved. \n\nI need to make sure the answer clearly states both points: the 70% identity for the S1 subunit overall and the high conservation in the RBD core. Also, note that unlike S2, S1 has lower identity but key regions are conserved. \n\nCheck if there's any other info. The context also mentions that most bat SARSr-CoVs have deletions in the spike RBD compared to human SARS-CoV, but 2019-nCoV and human SARS-CoV don't have those deletions. However, the question is about S1 subunit comparison, so maybe that's not directly relevant here. \n\nSo the answer should focus on the 70% identity and the conserved RBD core. Make sure to mention both SARS-like CoVs (bat) and human SARS-CoV as the comparison groups.\n</think>\n\nThe S1 subunit of 2019-nCoV shares **around 70% identity** with the S1 subunits of the two bat SARS-like coronaviruses (SARSr-CoVs) and human SARS-CoV. However, while the overall identity is moderate, the **core domain of the receptor binding domain (R",
      "retrieved_chunks": [
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b.",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "These findings provide the basis for\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: As shown in Figure 7 , the SARS-CoV 5 \u2032 -UTR contains SL1, SL2, SL3, SL4, S5, SL5A, SL5B, SL5C, SL6, SL7, and SL8.",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved )."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and they provided some context from a passage. I need to use the information given to form an accurate answer.\n\nFirst, I'll look through the context. The passage mentions that Bacillus species, specifically B. subtilis, are found in traditional fermented foods and are used in probiotics. It also says that unlike Lactobacillus, Bacillus wasn't considered part of the normal intestinal microbiome but has been found in feces. The passage explains that B. subtilis helps restore gut microflora by increasing beneficial bacteria like Bifidobacterium and Lactobacillus while reducing harmful ones like Acinetobacter and Clostridium. Additionally, it produces surfactins, fengycins, and iturins in a specific ratio. There's also a mention of their presence in decomposing plants and environments.\n\nSo, putting this together, Bacillus subtilis is a species of Bacillus that's used as a probiotic. It's part of the secretome in the intestines, helping to maintain a healthy gut by balancing the microbiome. The key points are its role in probiotics, its effect on gut flora, the antimicrobial substances it produces, and its presence in fermented foods and the environment. I should make sure to mention all these aspects in the answer. Also, note that it's not traditionally considered part of the normal gut microbiome but is beneficial when administered. The answer should be concise but cover these main points.\n</think>\n\nBacillus subtilis is a species of the Bacillus genus, historically found in traditional fermented foods and increasingly recognized for its probiotic properties. It functions as a \"natural guard\" against intestinal pathologies by restoring gut microbiota balance: it promotes beneficial bacteria (e.g., Bifidobacterium, Lactobacillus) and suppresses harmful species (e.g., Clostridium, Acinetobacter). It produces antimicrobial compounds like surfactins, fengycins, and iturins (in a 6:37:57 ratio) to combat pathogens. Though not traditionally classified as part of the normal intestinal microbiome, it is now used in probiotics (e.g., Biosubtyl, Enterogermina) and is associated with fermented foods and decomposing plant environments.",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "subtilis restored balance in gut microflora: beneficial species of Bifidobacterium, Lactobacillus, and Butyricicoccus spp. were increased, while gut damage-promoting species of Acinetobacter sp., Ruminococcus sp., Clostridium spp., and Veillonella sp.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. First, I need to look through the provided contexts to find any mentions of such research.\n\nLooking at the first context, it talks about the 1889 pandemic having three major waves, with the 1892 wave being the most intense. It also mentions the 1918 pandemic's herald waves possibly starting in 1915. However, this seems to be about multi-wave pandemics, not single-wave. The second context discusses the 2009 H1N1 pandemic in Hong Kong. They mention studies on the origins and pathogenesis of the 2009 strain, but it's not clear if it was a single wave. The third context is about economic analysis of mitigation strategies across five severity categories but doesn't specify single-wave. The fourth context from Taiwan discusses the 2009 pH1N1 pandemic using a Richards model for multi-wave epidemics. \n\nWait, the user is asking about severe, single-wave pandemics. The contexts provided mostly discuss pandemics with multiple waves, like the 1889, 1918, and 2009 examples. The 2009 pandemic in the Hong Kong context had multi-wave aspects too. The only possible mention of a single-wave is the 1892 wave being the most intense on the East Coast, but the overall pandemic had three waves. The answer might be that the contexts don't mention single-wave pandemics, but maybe the user is referring to the 1918 fall wave? However, the first context suggests that the 1918 pandemic had herald waves starting earlier. \n\nWait, the first passage says that viruses with similar genomes to the fall wave were circulating in early 1918 before the pandemic was recognized. The 1918 pandemic is known for having multiple waves, so maybe the fall wave is considered a single wave in some contexts? But the question is about severe, single-wave pandemics. The answer might be that the research mentioned in the contexts doesn't focus on single-wave pandemics but rather on multi-wave ones. However, the user is asking what past research has been done on single-wave. Since the provided contexts don't mention any single-wave pandemics, perhaps the answer is that the research discussed here focuses on multi",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review."
      ],
      "computed_relevance": 0.25,
      "computed_utilization": 0.25,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking \"How many reported viral pneumonia?\" based on the provided context. Let me go through each passage carefully to find any numbers related to viral pneumonia cases.\n\nFirst, looking at the first context about pneumonia in adults with influenza in the US from 2005-2008. The passage mentions that patients with pneumonia were more likely to receive antiviral therapy, but it doesn't give a specific number of cases. So probably not here.\n\nNext, the second context is about the 2019-nCoV (now known as COVID-19) rapid advice guideline. The passage states that as of January 26, 2020, there were 2744 confirmed cases of pneumonia with 2019-nCoV infection. That's a specific number. Also, later in the same context, it mentions 51 cases cured and discharged, 5794 suspected cases, etc. But the confirmed cases are 2744. This seems relevant.\n\nThird context is a clinical review on primary influenza viral pneumonia. It talks about attack rates, like 10-20% during seasonal epidemics, 29% in adults and 61% in children during the 2009 H1N1 pandemic in La Gloria. But these are percentages, not actual numbers of cases. The question is asking for how many were reported, so unless there's a specific number here, this might not be the answer.\n\nAnother part of the second context mentions confirmed cases from Hong Kong, Macao, and Taiwan, but the exact number isn't provided here. The main confirmed number given is 2744 from the National Health Commission.\n\nAnother part of the context mentions 583 people released from medical observation and 30,453 still under observation, but those are contacts, not cases of pneumonia.\n\nThe fourth passage in the clinical review about bacterial co-infection in H1N1 mentions 77 fatal cases, but again, that's about bacterial co-infection, not the total viral pneumonia cases.\n\nSo the only specific number given for reported viral pneumonia cases is 2744 confirmed cases of pneumonia with 2019-nCoV infection. The other numbers are either percentages, suspected cases, or related to contacts. Therefore, the answer should be 274",
      "retrieved_chunks": [
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation.",
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients ."
      ],
      "computed_relevance": 0.1111111111111111,
      "computed_utilization": 0.2222222222222222,
      "computed_completeness": 0.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The passage also mentions that MERS-CoV was the first to have such widespread use of deep sequencing for studying an emerging viral outbreak. \n\nI should check the other passages to make sure there's no conflicting information. The second passage talks about genetic recombination and subgenomic sequencing but doesn't contradict the first point. The third passage discusses genome analyses focusing on specific regions like the spike protein, but again, the main method mentioned is still whole genome sequencing. The fourth passage mentions vigilance due to the virus's genetic instability but doesn't add another method.\n\nSo the key point here is high throughput or deep sequencing for complete genome deduction. The answer should reflect that. I need to make sure to paraphrase correctly and include the main method as stated in the context.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been conducted using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach has been pivotal in studying the virus's genetic variations, travel patterns, and recombination events, marking MERS-CoV as the first emerging viral outbreak to be extensively analyzed through such advanced sequencing techniques.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "The technique can produce genomic .",
        "Earlier and subsequent versions of this chart are maintained on a personal blog length coverage in a single experiment with highly repetitious measurement of each nucleotide position ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look at the provided contexts to find the answer.\n\nFirst, looking at the first context titled \"Accelerated viral dynamics in bat cell lines...\" The passage mentions that after applying an overlay, plates were monitored using an inverted fluorescence microscope until the first signs of GFP expression were seen. They also mention that one color channel was imaged, showing GFP-expressing cells in white and others in black. So, they used fluorescence microscopy to monitor GFP expression over time.\n\nThe second context is about a study using a split-GFP-tagged viral protein. Here, they talk about transduction with MLV particles and concentration methods. They mention that after intranasal inoculation, certain percentages of dendritic cells, macrophages, and neutrophils expressed GFP. They tracked expression during passaging using immunofluorescence microscopy with a GFP antibody. So, they used immunofluorescence microscopy here.\n\nPutting this together, the methods mentioned are fluorescence microscopy and immunofluorescence microscopy. The first context uses fluorescence microscopy directly to observe GFP expression, while the second uses immunofluorescence with an antibody. However, since the question is about tracking the spread, the primary method seems to be fluorescence microscopy as they monitored over time. The answer should combine both methods if both are relevant, but need to check the exact wording.\n\nWait, the first context says \"monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed.\" The second context says \"Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody.\" So both methods are used in different contexts. The answer should mention both if they are part of the tracking. However, the question is about tracking the spread, which likely refers to observing the cells over time. The first method uses fluorescence microscopy to track as they monitor periodically. The second uses immunofluorescence during passaging. The answer might need to mention both, but maybe the main one is fluorescence microscopy. Let me check the exact question again.\n\nThe question is asking how the spread was tracked. The first context's method is monitoring with fluorescence microscopy, which would allow them to see the spread over time. The second context's method is using immunofluorescence during passaging, which might be for detecting presence but not necessarily",
      "retrieved_chunks": [
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .",
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator .",
        "The authors found that using a 10 6 PFU intranasal inoculation, 10% of dendritic cells were observed to express GFP and 2%-3% of macrophages and neutrophils were also GFP+ at 48 h post-infection .",
        "Expression of GFP was monitored during passaging by immunofluorescence microscopy using the GFP antibody."
      ],
      "computed_relevance": 0.4,
      "computed_utilization": 0.4,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures. \n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CT disinfection, and preparing to disinfect imaging equipment immediately after examination.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"noncontaminated CT disinfection procedures\" might be a bit confusing, but it likely refers to the standard disinfection process even if the CT wasn't contaminated, just as a precaution. \n\nSince the answer should be based on the provided context, I need to make sure I don't add external information. The context doesn't specify the exact steps (like which disinfectants to use or how long to wait), but it does emphasize immediate disinfection after the exam. So the answer should focus on the timing and the fact that procedures are in place for CT scanners post-examination for suspected cases. \n\nI should check if there's any mention of specific steps. The passages mention \"preparing to disinfect the imaging equipment immediately after the examination.\" So the main points are: immediate disinfection, after the examination, and for suspected cases. The answer should probably state that the recommended procedure is to disinfect the CT scanner immediately after the examination using established sterilization protocols.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a suspected COVID-19 case involves **immediately disinfecting the imaging equipment following the examination** using established sterilization protocols. The context emphasizes that healthcare personnel prepare to disinfect the CT equipment promptly after the procedure to mitigate contamination risks, ensuring safety for subsequent use. Specific steps likely include using approved disinfectants and adhering to guidelines for noncontaminated CT sterilization as outlined in emergency management protocols.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}